The founders of Metsera have a battle to buy their company. It would be their second time striking deal gold.

Oral GLP-1 weight loss pills could replace injections by March 2026 at $150 monthly, Medicare chief Dr. Mehmet Oz predicted ...

Novo Nordisk’s oral semaglutide 25 mg achieved up to 16.6% weight loss in a landmark study, rivaling injectable Wegovy. The ...

The idea of supplements replacing a balanced diet has become increasingly popular, with many believing that popping pills can give them all the nutrients they need ...

New study has discovered a groundbreaking technology that is showing remarkable success in significantly reducing bad ...

New versions of drugs like Wegovy, Ozempic, Mounjaro and Zepbound, including pills, will be easier to take, more effective ...

Wegovy-maker Novo Nordisk presented new data on Wednesday showing its experimental weight-loss pill improved blood sugar ...

A Trump administration deal to cut prices for popular weight-loss drugs like Wegovy and Zepbound will allow millions more ...

Novo Nordisk and Eli Lilly said they've agreed to sell their blockbuster drugs Wegovy and Zepbound at a discount.

Donald Trump hailed his deal to slash the price of blockbuster weight loss drugs as a game changer. But major gaps in the ...

The Trump administration initially walked back a Biden-era attempt to broaden Medicare coverage of weight loss drugs, which ...

In a world that chases fitness and wellness amidst the hustle of daily lives, weight loss jabs have become the magic pills ...